| Gebruikt door |
als |
Naam |
Versie |
| 2.16.840.1.113883.2.4.3.11.60.121.10.33 |
Inclusie |
 uitvoerende zorgaanbieder (3.4)
|
2021‑07‑01 |
| 2.16.840.1.113883.2.4.3.11.60.121.10.37 |
 |
zorgverlener (assigned contents) (3.5)
|
2021‑07‑01 |
| 2.16.840.1.113883.2.4.3.11.60.121.10.32 |
|
auteur
|
2021‑07‑01 |
| 2.16.840.1.113883.2.4.3.11.60.26.10.10 |
|
 cio reactie
|
2021‑07‑01 |
| 2.16.840.1.113883.2.4.3.11.60.26.10.23 |
|
cio bewakingbesluit
|
2023‑12‑08 16:10:29 |
| 2.16.840.1.113883.2.4.3.11.60.26.10.8 |
|
cio bewakingbesluit concern act
|
2021‑07‑01 |
| 2.16.840.1.113883.2.4.3.11.60.26.10.18 |
|
Organizer MedicationHypersensitivity
|
2023‑04‑19 |
| 2.16.840.1.113883.2.4.3.11.60.26.10.19 |
|
cio medicatie contraindicatie
|
2023‑12‑05 10:57:39 |
| 2.16.840.1.113883.2.4.3.11.60.26.10.14 |
|
cio medicatie contraindicatie concern act
|
2023‑04‑19 |
| 2.16.840.1.113883.2.4.3.11.60.26.10.7 |
|
Organizer MedicationContraIndication
|
2020‑08‑27 |
| 2.16.840.1.113883.2.4.3.11.60.26.10.9 |
|
cio overgevoeligheid
|
2021‑07‑01 |
| 2.16.840.1.113883.2.4.3.11.60.121.10.34 |
|
zorgverlener (assignedEntity) (3.5)
|
2021‑07‑01 |
| 2.16.840.1.113883.2.4.3.11.60.121.10.38 |
|
informant
|
2021‑07‑01 |
| 2.16.840.1.113883.2.4.3.11.60.121.10.43 |
|
uitvoerder
|
2021‑07‑01 |
| 2.16.840.1.113883.2.4.3.11.60.26.10.22 |
|
cio diagnose
|
2023‑12‑08 10:48:30 |
| 2.16.840.1.113883.2.4.3.11.60.3.10.0.15 |
Inclusie |
relatedEntity
|
2018‑06‑11 |
| 2.16.840.1.113883.2.4.3.11.60.3.10.1 |
Inclusie |
CDA recordTarget SDTC NL
|
2021‑07‑01 |
